Author:
Fukunaga A K,Marsh S,Murry D J,Hurley T D,McLeod H L
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference46 articles.
1. Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC et al. Evaluation of the antitumor activity of Gemcitabine (2′,2′-difluoro-2′deoxycytidine). Cancer Res 1990; 50: 4417–4422.
2. Peters GJ, Plunkett W . Introduction: Gemcitabine-status of preclinical studies and perspectives for future clinical applications of this novel nucleoside analog. Semin Oncol 1995; 22: 1–2.
3. Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB . Phase III study of gemcitabine in combination with fluorouracil vs gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 2002; 20: 3270–3275.
4. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003; 95: 362–372.
5. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92–98.
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献